HL
The startup has developed a biotechnology platform that analyzes the structural composition of DHA genomes to facilitate the creation of Ultra-Absorbable Omega-3 fatty acids and potent antioxidants. This technology enables medical researchers to enhance the bioavailability and efficacy of nutraceuticals, addressing the need for more effective dietary supplements.
Updated 3 months ago
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a biotechnology platform that analyzes the structural composition of DHA genomes to facilitate the creation of Ultra-Absorbable Omega-3 fatty acids and potent antioxidants. This technology enables medical researchers to enhance the bioavailability and efficacy of nutraceuticals, addressing the need for more effective dietary supplements.